Concord Hospital is a non-profit hospital located in the West End of Concord, New Hampshire. It is the principal site of the Concord Hospital regional health system which serves central New Hampshire, and is a clinical teaching site of the Dartmouth Geisel School of Medicine, New Hampshire's only medical school.

There are 295 beds in Concord Hospital.

During the past decade, Concord Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Concord Hospital" #1 sponsor was "Dartmouth-Hitchcock Medical Center" with 4 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored, "Franklin Pierce University" with 2 trials sponsored and "Abiomed Inc." with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Concord Hospital" #1 collaborator was "NRG Oncology" with 6 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Concord Hospital" with 2 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator and "MGH Multiple Sclerosis Clinic" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Concord Hospital" are "Prostate Cancer" (3 trials), "Ankle Sprain" (1 trials), "Bacterial Vaginosis" (1 trials), "Cannabis-Related Disorder" (1 trials) and "Esophageal Adenocarcinoma" (1 trials). Many other conditions were trialed in "Concord Hospital" in a lesser frequency.

Most popular intervention types in "Concord Hospital" are "Drug" (8 trials), "Other" (6 trials), "Radiation" (6 trials), "Behavioral" (2 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Laboratory Biomarker Analysis" (2 trials), "Paclitaxel" (2 trials), "Placebo" (2 trials) and "Quality-of-Life Assessment" (2 trials). Other intervention names were less common.

The vast majority of trials in "Concord Hospital" are 12 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Concord Hospital". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Concord Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Concord Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".

Concord Hospital has several departments that took part in Clinical trials: "Payson Center for Cancer Care at Concord Hospital" - 7 trials, "Concord Hospital Rehabilitation Services" - 2 trials